Wednesday, September 29, 2021

DNA diagnostic market is expected to grow at a CAGR of 9%-12% by 2026 - An exclusive market research report by Lucintel

DNA diagnostic market is expected to grow at a CAGR of 9%-12% by 2026 - An exclusive market research report by Lucintel
Trends and Forecast for the Global DNA Diagnostic Market
Trends, opportunities and forecast in DNA diagnostic market to 2025 by product (instruments, reagents, and service & software), technology (microarray based, PCR based, In-situ hybridization, NGS DNA diagnosis), application (pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/P450 effects), & region

Lucintel's latest market report analyzed that DNA diagnostic provides attractive opportunities in applications, such as pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/p450 effects. The DNA diagnostic market is expected to grow at a CAGR of 9%-12%. In this market, instruments are the largest segment by product, whereas infectious disease diagnostics are largest by application.    

Download Brochure of this report by clicking on https://www.lucintel.com/dna-diagnostic-market.aspx

Based on product, the DNA diagnostic market is segmented into instruments, reagents, and service & software. The instruments segment accounted for the largest share of the market in 2020 due to improved healthcare facilities, availability of user-friendly instruments, their competitive cost structure, reliability, and size.

Browse in-depth TOC on “DNA Diagnostic Market”

XX – Tables

XX – Figures

150– Pages

The DNA diagnostic market is marked by the presence of several big and small players. Some of the prominent players offering DNA diagnostic include GE Healthcare, Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Cephide, Hologic, Transgenomic, Siemens Healthcare, Roche Diagnostics, and Qiagen.  

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Media Contact
Company Name: Lucintel
Contact Person: Brandon Fitzgerald
Email:Send Email
Phone: 303.775.0751
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: www.lucintel.com